According to the 2025 National Survey on Drug Use and Health, in the United States, among people 12 years of age and older, 36.1 million smoke tobacco cigarettes and 29.3 million vape nicotine electronic cigarettes (also referred to as e-cigarettes, vaping, e-vaping, and ENDS-electronic nicotine delivery systems). These numbers are concerning considering the health risks of both.
Nicotine Replacement Therapies and a Special Note about E-Cigarettes
FDA-approved nicotine replacement therapies, such as patches, gum, and lozenges, remain preferred first-line options because their safety and effectiveness are better established. However, electronic cigarettes may serve as a nicotine replacement strategy for adults who smoke tobacco cigarettes and have been unsuccessful with, or are unable to tolerate, traditional smoking cessation therapies. By delivering nicotine without burning tobacco, e-cigarettes can substantially reduce exposure to many of the harmful chemicals found in cigarette smoke. They may help some individuals transition away from tobacco cigarette use.
However, e-cigarettes are not risk-free. E-cigarette aerosols can contain ultrafine particles, heavy metals such as nickel, tin, and lead, volatile organic compounds, and possibly formaldehyde, which is a carcinogenic chemical. E-vaping can cause lung damage with respiratory symptoms including coughing, wheezing, and shortness of breath. Nicotine itself is highly addictive and can adversely affect cardiovascular health. Therefore, e-cigarettes may be viewed as a potential harm-reduction tool rather than a healthy alternative to smoking. Its use should be limited to adults who currently smoke, with the goal of completely transitioning away from tobacco cigarettes and ultimately discontinuing nicotine use. Individuals who do not smoke, adolescents, and pregnant women should avoid e-cigarettes.
Smoking Cessation Treatment Options
Alongside prescription pharmacotherapies including varenicline, bupropion, and nicotine replacement therapy, complementary and integrative approaches may further support people to quit smoking and/or vaping, particularly when therapy options address nicotine cravings, stress, withdrawal symptoms, and the behavioral habits associated with nicotine use.
Acupuncture
Some studies suggest acupuncture may reduce cravings or improve short-term abstinence. A 2024 umbrella review and meta-analysis analyzed 13 systematic reviews and 20 randomized controlled trials. The analysis concluded that while some reviews were of low quality and some trials had bias, the results found a relative improvement compared with sham acupuncture, and that “acupuncture and auricular acupressure appear to be safe and effective in achieving short-term smoking cessation.”
https://pubmed.ncbi.nlm.nih.gov/38638420/
Naturopathy
Cytisine (also known as cytisinicline) is a plant-derived medication that can support smoking cessation by partially stimulating nicotinic acetylcholine receptors in the brain. This helps reduce nicotine cravings and withdrawal symptoms while also diminishing the rewarding effects of smoking. Because nicotine dependence is also a major factor in vaping, cytisine may offer potential benefits for vaping cessation as well. Studies show cytisine has similar efficacy to varenicline and better results than nicotine replacement therapy. Although cytisine has been used for decades in Central and Eastern Europe and is approved in several countries, including Canada as an over-the-counter medication, it is not currently FDA-approved or commercially available as a prescription medication in the United States. As of November 2026, the manufacturer is pursuing FDA approval for cytisinicline, the name used for its updated formulation and dosing regimen. The company anticipates potential approval in 2027. Cytisinicline may be an option for patients who previously tried varenicline and had difficulty with side effects.
The following clinical trial concluded that “Both 6- and 12-week cytisinicline schedules, with behavioral support, demonstrated smoking cessation efficacy and excellent tolerability, offering new nicotine dependence treatment options.”
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial - PubMed
Tellus Wellness is monitoring the regulatory approval process for this promising smoking cessation medication. We recognize its potential to expand treatment options for individuals seeking to quit smoking and will share updates on its approval status and availability when more information is available. Please visit our website for future developments.
Massage
Although there is insufficient high-quality evidence that massage itself increases quit rates or prevents relapse, massage therapy may reduce anxiety, muscle tension, and perceived stress during nicotine withdrawal. Attempts at smoking cessation have been correlated with severe withdrawal symptoms, including intense cigarette cravings, anxiety, and depressed mood. Massage therapy has been shown to reduce anxiety and stress hormones and improve mood. Massage therapy may be considered an adjunct comfort measure rather than a cessation treatment.
The following small study included “20 adult smokers who were randomly assigned to a self-massage treatment or a control group. The treatment group was taught to conduct a hand or ear self-massage during 3 cravings a day for 1 month. Self-reports revealed lower anxiety scores, improved mood, and fewer withdrawal symptoms. In addition, the self-massage group smoked fewer cigarettes per day by the last week of the study.”
Smoking cravings are reduced by self-massage - PubMed
Nutritional Counseling
Nutritional counseling may be a valuable adjunct to smoking cessation treatment, particularly for individuals concerned about post-cessation weight gain. Clinical trials have examined structured dietary education, individualized weight-management programs, and multidisciplinary interventions that combine nutrition, exercise, and behavioral counseling. Although results have been mixed, evidence suggests that personalized weight-management support incorporating individualized goals, dietary assessment, and ongoing feedback may be more effective than generalized dietary education alone. Nutritional counseling may also improve dietary quality and cardiometabolic health, even when it does not achieve significant reductions in weight gain. Current evidence supports integrating individualized nutritional guidance into smoking cessation programs while prioritizing sustained tobacco abstinence over restrictive weight-control strategies.
The following study aimed to determine the effect of a structured nutritional counseling program on weight change and food choice in adults attempting smoking cessation. “Improved quit rates in the intervention group suggest that continued contact with advisors may have reduced anxieties regarding weight gain and encouraged cessation despite weight gain.”
Complementary therapies can be helpful as adjunct therapies to improve comfort, motivation, and adherence for cigarette smoking and/or e-vaping cessation.
References
- Zhang YY, Su YZ, Tian ZY, Liang SB, Liu YJ, Li YF, Qiao HF, Robinson N, Liu JP. Acupuncture and related acupoint therapies for smoking cessation: An umbrella review and updated meta-analysis. Tob Induc Dis. 2024 Apr 18;22. doi: 10.18332/tid/186147. PMID: 38638420; PMCID: PMC11025526.
- Rigotti, Nancy A et al. “Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.” JAMA vol. 330,2 (2023): 152-160. doi:10.1001/jama.2023.10042
- Hernandez-Reif, M et al. “Smoking cravings are reduced by self-massage.” Preventive Medicine vol. 28,1 (1999): 28-32. doi:10.1006/pmed.1998.0372
- Leslie, Wilma S et al. “Changes in body weight and food choice in those attempting smoking cessation: a cluster randomised controlled trial.” BMC Public Health vol. 12 389. 29 May. 2012, doi:10.1186/1471-2458-12-389